Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per L

BACKGROUND: ALT testing of blood donors was initiated as a surrogate marker for non‐A, non‐B hepatitis. Increased sensitivity of subsequent HBV and HCV tests used for standard donor screening make any residual value of ALT testing questionable.

[1]  L. Smith,et al.  Transfusion–Transmitted Viruses , 2003, American Society for Clinical Laboratory Science.

[2]  J. Kiss,et al.  Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion Recipients , 1998, Vox Sanguinis.

[3]  A. Widell,et al.  Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels , 1998, Transfusion.

[4]  E. Seifried,et al.  Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients , 1997, Transfusion.

[5]  R. Cable,et al.  Limited utility of alanine aminotransferase screening of hepatitis C antibody‐screened blood donors , 1997, Transfusion.

[6]  K. Stark,et al.  Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[7]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[8]  S. Kleinman,et al.  Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study , 1995, Transfusion.

[9]  W. H. Hall,et al.  Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. , 1995, JAMA.

[10]  W. H. Hall,et al.  Infectious disease testing for blood transfusions. , 1995, NIH consensus statement.

[11]  G. Vyas,et al.  Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase , 1994, Transfusion.

[12]  P. Wutzler,et al.  Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. , 1993, Journal of virological methods.

[13]  L. Mimms,et al.  Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays , 1991, Journal of medical virology.

[14]  M. Williams,et al.  Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV. , 1988, The Journal of infectious diseases.

[15]  G. Vyas,et al.  Viral hepatitis : a contemporary assessment of etiology, epidemiology, pathogenesis, and prevention : proceedings of the Second Symposium on Viral Hepatitis, University of California, San Francisco, March 16-19, 1978 , 1978 .